These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6999952)

  • 1. The control of hypertension: a therapeutic breakthrough.
    Kaplan NM
    Am Sci; 1980; 68(5):537-45. PubMed ID: 6999952
    [No Abstract]   [Full Text] [Related]  

  • 2. [Renin-angiotensin-aldosterone system in essential hypertension. Inappropriately high plasma aldosterone in young patients with severe hypertension and in older hypertensives].
    Vetter H; Zumkley H; Glänzer K; Witassek F; Wollnik S; Vetter W
    Schweiz Med Wochenschr; 1980 Dec; 110(50):1938-41. PubMed ID: 7010579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic progress in the area of arterial hypertension].
    Verniory A; Demanet JC
    Brux Med; 1974 Oct; 54(10):551-8. PubMed ID: 4373143
    [No Abstract]   [Full Text] [Related]  

  • 5. [Arterial hypertension - individual risk stratification and therapeutic targets].
    Weisser B; Düsing R; Mengden T
    Dtsch Med Wochenschr; 2001 Nov; 126(44):1235-41. PubMed ID: 11687983
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pathogenesis of arterial hypertension].
    Shul'ga IuD; Adibaev OA; Cherniakova IA; Sadchikova VA; Kondratskaia LV; Kogan IA
    Vrach Delo; 1980 Mar; (3):43-7. PubMed ID: 6990624
    [No Abstract]   [Full Text] [Related]  

  • 7. [Renin-angiotensin-aldosterone system in water-electrolyte homeostasis].
    Anghel S
    Med Interna (Bucur); 1972 May; 24(5):521-8. PubMed ID: 4340438
    [No Abstract]   [Full Text] [Related]  

  • 8. Pediatric hypertension: diagnosis, evaluation, management, and treatment for the primary care physician.
    Portman RJ; McNiece KL; Swinford RD; Braun MC; Samuels JA
    Curr Probl Pediatr Adolesc Health Care; 2005 Aug; 35(7):262-94. PubMed ID: 16077462
    [No Abstract]   [Full Text] [Related]  

  • 9. [Arterial hypertension and oral contraceptives].
    Gaja R; Thoulon JM
    Lyon Med; 1971 Dec; 226(19):703-12. PubMed ID: 4334031
    [No Abstract]   [Full Text] [Related]  

  • 10. The classification and treatment of essential hypertension using the renin-sodium index for vasoconstriction-volume analysis.
    Laragh JH
    Johns Hopkins Med J; 1975 Oct; 137(4):184-94. PubMed ID: 1185911
    [No Abstract]   [Full Text] [Related]  

  • 11. Antihypertensive persistence and drug class.
    Marentette MA; Gerth WC; Billings DK; Zarnke KB
    Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of aldosterone in left ventricular hypertrophy in hypertension.
    Matsumura K; Fujii K; Oniki H; Oka M; Iida M
    Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension: selection of treatment in relation to the mechanisms raising blood pressure.
    Conway J
    Brux Med; 1973 Nov; Spec No(0):87-98. PubMed ID: 4371910
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies in preventive nephrology: blood pressure and proteinuria in the population.
    Soyannwo MA
    Afr J Med Med Sci; 2003 Mar; 32(1):81-3. PubMed ID: 15030072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in the renin-angiotensin-aldosterone system during graduated ergometric tests in patients with essential arterial hypertension and in normal controls].
    Marchezotti AV; Feldstein CA; Leber B; Burucúa JE; Vilches AM; Varela de Rodríguez J
    Rev Clin Esp; 1981 May; 161(3):145-8. PubMed ID: 7022582
    [No Abstract]   [Full Text] [Related]  

  • 17. Aldosterone excess and resistance to 24-h blood pressure control.
    Pimenta E; Gaddam KK; Pratt-Ubunama MN; Nishizaka MK; Cofield SS; Oparil S; Calhoun DA
    J Hypertens; 2007 Oct; 25(10):2131-7. PubMed ID: 17885558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE inhibitor-based treatment and antihypertensive effects in patients with type 2 diabetes.
    Jarmuzewska EA; Rocchi R; Guidoni A; Mangoni AA
    Panminerva Med; 2008 Sep; 50(3):207-16. PubMed ID: 18927524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the role of renin/angiotensin-targeted antihypertensive therapy in decreasing cardiovascular risk: evidence, guideline evolution, and questions to be resolved.
    Probstfield J
    J Fam Pract; 2009 Jun; 58(6 Suppl):S1-8. PubMed ID: 19508849
    [No Abstract]   [Full Text] [Related]  

  • 20. The renin-angiotensin-aldosterone system: focus on its distinct role in arterial hypertension and its various inhibitors as a therapeutic strategy to effectively lower blood pressure.
    Soldner A; Spahn-Langguth H; Mutschler E
    Pharmazie; 1996 Nov; 51(11):783-99. PubMed ID: 8985974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.